DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Kai H, Kai M.
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
Hypertens Res 2020;
43 (07) 648-654
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.